Urgent high quality communications from across the chemical sciences.
Impact Factor 6.378 100 Issues per Year Indexed in MEDLINE
Communication

Programmable drug release using bioresponsive mesoporous silica nanoparticles for site-specific oral drug delivery

Show Affiliations
Hide Affiliations
*
Corresponding authors
a
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia
E-mail: c.yu@uq.edu.au;
Fax: +61 7 3346 3973 ;
Tel: +61 7 3346 3283
b
The School of Pharmacy, The University of Queensland, Brisbane, Australia
c
Mucosal Diseases Group, Mater Research Institute – The University of Queensland, Translational Research Institute, 37 Kent St, Woolloongabba, Australia
Chem. Commun., 2014,50, 5547-5550

DOI: 10.1039/C4CC00620H
Received 24 Jan 2014, Accepted 17 Feb 2014
First published online 17 Feb 2014
| | | | | | More
Please wait while Download options loads
Download Citation
 
 

Supplementary Info